Cannabis users under 50 are 6 times more likely to have a heart attack, new study shows
A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than their counterparts.
Novo says Ozempic succeeded in late-stage trial for peripheral artery disease
Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...
Endovascular Today2d
Vasorum’s Celt ACD Plus Vascular Closure Device Approved by FDA
Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...
Vasorum Announces FDA Approval of its Celt ACD® PLUS Vascular Closure Device
Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug Administration (FDA) approval of the Celt ACD® ...
Endologix Announces 1000 patients treated with the DETOUR™ System
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that 1,000 patients ...
MassDevice5d
Abbott is making an IVL play with FDA IDE nod
Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.